Technology:

Biotechnology, MedTech, Clinical Diagnostics, Genomics, Proteomics AI, Oncology, Medical Devices (AI), Cell and Gene Therapy, Surgical and Hospital, Personalized Medicine.

Operating:

Leadership, Innovative Strategy and Business Development, EBITDA/Revenue Growth, Fortune 100s and Startups, P&L Responsibility (1.4B), Building/Leading High Performance Teams, Fundraising, Sales and Marketing, Cybersecurity/Risk, Compliance, M&A/Integration, Go-to-Market, Commercialization, Product Launch, Global Expansion, Partnering, Supply Chain, Acquisitions/Exits, Hospital IDN/GPO/HMO Contracting, Establishing Culture Diversity, Equity and Inclusion, Board Governance: Audit, Nom/Gov, Compensation, CEO Succession.

Scale:

Early-Stage/Start-up, Emerging Growth to Acquisition, mid/late-stage to IPO, VC and PE Funded, Private and Public Companies, Fortune 100 Global Public Companies.